Novavax ($NVAX) riding the waves
|Continuing along the theme of Corona Virus stocks, this week Novavax Inc. is next up in line. Novavax has gone parabolic with the COVID-19 spreading worldwide as with the other names I have covered. It also remains very technical, and I think there could a few more swings up before a longer term top is realized. Lets take a look at what they do as a company:
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. Our vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis.
Novavax has had an impressive rally so far this year. Also, the structure of this stock looks a lot better than many other plays I have covered in the COVID-19 related fields. With that said, the Elliott Wave view seems to be counting technically clean. Let’s take a look below at the 4H view.
Novavax 4H Elliott Wave View
Novavax set all time lows in November 2019 at 3.54. From there Novavax had a clean 5 waves advance shown in blue, for a wave ((1)) top at 17.71. From there wave ((2)) is set at 6.77 and a wave ((3)) advance is currently underway. Prices have reached the equal legs extreme area of ((1))-((2)) as shown above, in a blue box. This is an area where sellers may enter for a pullback in 3, 7 or 11 waves. Prices entered the box and found resistance to pullback in a blue (4) of ((3)).
Prices still have a bit more upside in wave ((3)) to complete the sequence before a pullback in wave ((4)) is expected. It’s a bit late in the cycle to start chasing new longs, but the target for ((3)) is the 161.8% extension at 30.38. After a wave ((4)) has played out in 3,7 or 11 waves, there is room for a wave ((5)) of Red I to complete the sequence.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.